BeiGene co-founder and ex-Viela Bio BD leader snag $200M for age-re­lat­ed biotech, with ARCH jump­ing in

3 years ago
Financing
China

Roche wins an edge in the hy­per­com­pet­i­tive race for PD-(L)1 mar­ket share

3 years ago
R&D
Pharma

With some neu­ro tar­gets in mind, Ab­b­Vie gets So­sei's drug dis­cov­ery en­gine churn­ing again

3 years ago
Deals
R&D

French biotech armed with Se­ries A looks to build out man­u­fac­tur­ing fa­cil­i­ty for plant-based pro­tein tech

3 years ago
Financing
Startups

An MIT pro­fes­sor's rare dis­ease quest rip­ples through­out biotech

3 years ago
People
In Focus

New biotech from Alex­is Borisy will test Mer­ck KGaA, Blue­print can­cer drug com­bo in bid to ful­fill Gleevec promise

3 years ago
Financing
Startups

Lit­tle biotech de­vel­op­ing Genen­tech castoff drug hits hur­dle in glioblas­toma plat­form tri­al

3 years ago
R&D

Ax­cel­la flunks long Covid PhII pri­ma­ry goal — but plots a path in­to PhI­II

3 years ago
R&D
Coronavirus

Un­der pres­sure from ad­vo­cates, Vi­iV strikes a deal to make its long-act­ing HIV in­jectable more ac­ces­si­ble

3 years ago
Deals
Pharma

Bio­gen's new SMA aware­ness cam­paign in Spain spot­lights the 'in­vis­i­ble' care­givers

3 years ago
Pharma
Marketing

J&J nabs la­bel ex­pan­sion for Ste­lara in pe­di­atric pso­ri­at­ic arthri­tis

3 years ago
Pharma
FDA+

Space, the fi­nal fron­tier for drug man­u­fac­tur­ing?

3 years ago
Pharma
Manufacturing

Ab­b­Vie's Al­ler­gan inks $2.3B+ opi­oid set­tle­ment with sev­er­al states

3 years ago
Pharma
Law

Bausch Health as­serts push to 'vig­or­ous­ly' de­fend Xi­fax­an patent lit­i­ga­tion 

3 years ago
Pharma
Law

Pri­or­i­ty re­view for Gami­da's cell ther­a­py; PhI­II shut­tered at Akari; Im­mutep drops da­ta on LAG3 study

3 years ago
News Briefing

Cash-strapped biotech flips ex-Med­Im­mune an­ti-in­flam­ma­to­ry drug for $15M cash

3 years ago
Deals

Celyad gets the go-ahead to re­sume CAR-T tri­al for col­orec­tal can­cer as FDA lifts hold

3 years ago
R&D
FDA+

Not yet in the clin­ic, Beam’s base-edit­ed, off-the-shelf CAR-T put on hold

3 years ago
R&D
Cell/Gene Tx

David Hung's Nu­va­tion Bio ax­es clin­i­cal pro­gram, lays off 30 af­ter re­searchers say they can't man­age the side ef­fects

3 years ago
People
R&D

Pos­i­tive PhI­II re­sults in hand, Con­cert Phar­ma forges ahead with NDA and com­mer­cial­iza­tion plans for hair loss drug

3 years ago
R&D

San Diego biotech fails PhII in ear-ring­ing and will cut costs in pipeline prun­ing

3 years ago
R&D

Re­gen­eron ends four clin­i­cal tri­als of its rolled-back Covid-19 an­ti­body

3 years ago
R&D
Pharma

Ipsen jumps in­to the TCR space, team­ing with start­up helmed by for­mer Mer­ck KGaA can­cer chief

3 years ago
Deals

As­traZeneca cuts PhI­II tri­al short af­ter next-gen check­point drug fails in­ter­im analy­sis

3 years ago
R&D
First page Previous page 481482483484485486487 Next page Last page
A service from the Financial Times